Search research articles
Contact Us
Filters
Showing results (171-180 of 190) with videos related to
Page
of 19
Sort By:
British Journal of Cancer
|
July 7, 2000
The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo
H T Zhang, P A Scott, L Morbidelli, et al.
International Journal of Oncology
|
June 15, 2000
Application of the enrichment approach to identify putative markers of response to 5-fluorouracil therapy in advanced colorectal carcinomas
J A McKay, C Lloret, G I Murray, et al.
The Lancet. Respiratory Medicine
|
January 17, 2014
Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial
Pallav L Shah, Zaid Zoumot, Suveer Singh, et al.
Cancer Research
|
March 1, 1997
Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis
M Relf, S LeJeune, P A Scott, et al.
British Journal of Cancer
|
February 1, 1996
The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium
S B Fox, M Westwood, A Moghaddam, et al.
The Journal of Pathology
|
April 18, 2000
Inactive matrix metalloproteinase 2 is a normal constituent of human glomerular basement membrane. An immuno-electron microscopic study
S M Jalalah, P N Furness, G Barker, et al.
Plos One
|
April 9, 2015
Endobronchial coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trial
Zaid Zoumot, Samuel V Kemp, Suveer Singh, et al.
Cancer Research
|
October 15, 1996
Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers
T S O'Brien, S B Fox, A J Dickinson, et al.
British Journal of Cancer
|
September 10, 2009
Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane
S L Maloney, D C Sullivan, S Suchting, et al.
Anticancer Research
|
August 5, 2003
Samarium-153 and technetium-99m-labeled monoclonal antibodies in angiogenesis for tumor visualization and inhibition
P Bouziotis, M Fani, S C Archimandritis, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 190) with videos related to
Sort By:
Page
of 19
British Journal of Cancer
|
July 7, 2000
The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo
H T Zhang, P A Scott, L Morbidelli, et al.
International Journal of Oncology
|
June 15, 2000
Application of the enrichment approach to identify putative markers of response to 5-fluorouracil therapy in advanced colorectal carcinomas
J A McKay, C Lloret, G I Murray, et al.
The Lancet. Respiratory Medicine
|
January 17, 2014
Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial
Pallav L Shah, Zaid Zoumot, Suveer Singh, et al.
Cancer Research
|
March 1, 1997
Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis
M Relf, S LeJeune, P A Scott, et al.
British Journal of Cancer
|
February 1, 1996
The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium
S B Fox, M Westwood, A Moghaddam, et al.
The Journal of Pathology
|
April 18, 2000
Inactive matrix metalloproteinase 2 is a normal constituent of human glomerular basement membrane. An immuno-electron microscopic study
S M Jalalah, P N Furness, G Barker, et al.
Plos One
|
April 9, 2015
Endobronchial coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trial
Zaid Zoumot, Samuel V Kemp, Suveer Singh, et al.
Cancer Research
|
October 15, 1996
Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers
T S O'Brien, S B Fox, A J Dickinson, et al.
British Journal of Cancer
|
September 10, 2009
Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane
S L Maloney, D C Sullivan, S Suchting, et al.
Anticancer Research
|
August 5, 2003
Samarium-153 and technetium-99m-labeled monoclonal antibodies in angiogenesis for tumor visualization and inhibition
P Bouziotis, M Fani, S C Archimandritis, et al.
Page
of 19